Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.
Press releases published on May 2, 2025
CloudOffix Accelerates Global Expansion with New Strategic Partnerships in Europe and MENA
EIN Presswire
·
May 2, 2025
CloudOffix Accelerates Global Expansion with New Strategic Partnerships in Europe and MENA CLAYMONT, DE, UNITED STATES, May 3, 2025 /EINPresswire.com/ -- CloudOffix, the pioneering low-code Total Experience Platform, announces plans to strengthen its …
AST Announces the Return of the IP3 for 2025 – A Unique Patent Purchase and Licensing Opportunity for Patent Owners
EIN Presswire
·
May 2, 2025
AST announces its tenth annual Industry Patent Purchase and Licensing Program - IP3 2025, connecting patent owners with major global technology firms. PRINCETON, NJ, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Allied Security Trust (AST) is excited …
Refundy revolutionizes e-commerce by automating 90% of seller tasks, emerging as a key global automation partner
EIN Presswire
·
May 2, 2025
Refundy automates 90% of e-commerce seller tasks with AI, helping global sellers boost efficiency and focus on growth amid rising online orders. PANGYO, GYEONGGI-DO, SOUTH KOREA, May 3, 2025 /EINPresswire.com/ -- As the global e-commerce market rapidly …
EIN Presswire’s Debut Edition of ‘Heard on the Streets': PR Expert Clears Up Important PR Misconception
EIN Presswire
·
May 2, 2025
Sherrie Handrinos discusses how to earn media coverage and the key differences between earned PR and paid placement WASHINGTON, DC, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- In the debut edition of “Heard on the Streets,” a new series on EIN …
RotaWiz to Showcase Innovative NDIS Rostering Solution at Sydney Disability Connection Expo 2025
EIN Presswire
·
May 2, 2025
MELBOURNE, MELBOURNE, 3170, AUSTRALIA, May 3, 2025 /EINPresswire.com/ -- RotaWiz, a trusted NDIS-compliant rostering software in Australia, is excited to announce its participation in the Sydney Disability Connection Expo 2025. The Disability Expo Sydney …
HPQ Files Annual Financial Disclosure
GlobeNewswire
·
May 2, 2025
MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing announces that, further to its April …
HPQ Silicium : dépose sa déclaration financière annuelle
GlobeNewswire
·
May 2, 2025
MONTRÉAL, 02 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans le développement de nouveaux procédés industriels annonce qu’à la suite de son …
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
GlobeNewswire
·
May 2, 2025
Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIA FDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025 MORRISVILLE, N.C., May 02, 2025 (GLOBE …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Vital Battery Metals Announces Name Change to Aventis Energy
GlobeNewswire
·
May 2, 2025
VANCOUVER, British Columbia, May 02, 2025 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce that the Company’s Board of Directors have approved a name change to “Aventis …
Result of General Meeting
GlobeNewswire
·
May 2, 2025
May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …
Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
GlobeNewswire
·
May 2, 2025
CHANDLER, Ariz., May 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced that Rick Cassidy, Senior Vice President of Corporate …
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
GlobeNewswire
·
May 2, 2025
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …
Update on Market Making Arrangements
GlobeNewswire
·
May 2, 2025
Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
May 2, 2025
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
GlobeNewswire
·
May 2, 2025
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
GlobeNewswire
·
May 2, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …